Your browser doesn't support javascript.
loading
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.
Abbaspour Babaei, Maryam; Kamalidehghan, Behnam; Saleem, Mohammad; Huri, Hasniza Zaman; Ahmadipour, Fatemeh.
Affiliation
  • Abbaspour Babaei M; Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Kamalidehghan B; Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Shahrak-e Pajoohesh; Medical Genetics Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Saleem M; Department of Urology; Department of Laboratory Medicine and Pathology, Masonic Cancer Center, University of Minnesota; Section of Molecular Therapeutics & Cancer Health Disparity, The Hormel Institute, Austin, MN, USA.
  • Huri HZ; Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Clinical Investigation Centre, University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Malaysia.
  • Ahmadipour F; Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Drug Des Devel Ther ; 10: 2443-59, 2016.
Article in En | MEDLINE | ID: mdl-27536065
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Signal Transduction / Receptor Protein-Tyrosine Kinases / Cell Proliferation / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Drug Des Devel Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: Malaysia Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Signal Transduction / Receptor Protein-Tyrosine Kinases / Cell Proliferation / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Drug Des Devel Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: Malaysia Country of publication: New Zealand